EUVIMEDEUVIMED entdecken
Crossref

Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura

Jennifer M Jones, Alesia Kaplan, Irina Chibisov, Janine Then, Enrico M Novelli, Joseph E Kiss

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05993-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Jennifer M Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Division of Transfusion Medicine, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109-5054, USA. jonjm@m…. Hauptthemen laut MEDLINE: Purpura, Thrombotic Thrombocytopenic, Single-Domain Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombotic ThrombocytopenicSingle-Domain AntibodiesHumansFemaleMaleMiddle AgedRetrospective StudiesAdultUnited StatesAgedTertiary Health CareTreatment Outcome

Stichwörter der Autor:innen

CaplacizumabImmune thrombotic thrombocytopenic purpuraOutcomesTherapeutic plasma exchange

Substanzen

caplacizumabSingle-Domain Antibodies

Autor:innen und Institutionen

  • Department of Pathology, Division of Transfusion Medicine, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109-5054, USA. jonjm@med.umich.edu.
  • Department of Medicine, Division of Hematology/Oncology, University of Michigan, 1500 E. Medical Center Dr, Ann Arbor, MI, 48109-5054, USA. jonjm@med.umich.edu.
  • Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Vitalant, Clinical Services, Northeast Division, Pittsburgh, PA, USA.
  • Department of Pharmacy and Therapeutics, UPMC Presbyterian Shadyside Hospital, Pittsburgh, PA, USA.
  • Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Zitieren

APA

Jones, J. M., Kaplan, A., Chibisov, I., Then, J., Novelli, E. M., & Kiss, J. E. (2024). Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura. Annals of Hematology. https://doi.org/10.1007/s00277-024-05993-5

Vancouver

Jones JM, Kaplan A, Chibisov I, Then J, Novelli EM, Kiss JE. Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura. Annals of Hematology. 2024. doi:10.1007/s00277-024-05993-5

BibTeX
@article{Jones2024,
  author = {Jones, Jennifer M and Kaplan, Alesia and Chibisov, Irina and Then, Janine and Novelli, Enrico M and Kiss, Joseph E},
  title = {Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05993-5}
}
Kostenlos starten →